Corticosteroids for COVID-19: the search for an optimum duration of therapy
Letter notes steroids need to be used judiciously, considering risk–benefit ratio, as short-course (e.g.≤10 days) in selected patients with COVID-19 for whom survival benefit has been reported. There is no evidence supporting long-term use to prevent potential adverse sequelae.
Source:
The Lancet Respiratory Medicine